YbaƱez, Conchita N.
HRN: 22-17-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/05/2022
11/11/2022
IV
1.5G
Q6
Wound Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes